Document:

EXHIBIT 10.10

                  STOCK PURCHASE AND RECAPITALIZATION AGREEMENT
                  ---------------------------------------------

     This Agreement this 27th day of February 2007 by and among BlueStar Health
Inc., a Colorado corporation ("Buyer"); and Zeon Fuel Inc. a Texas corporation
(the "Company").

                                    RECITALS

     A. The respective Boards of Directors of each of the Company and Buyer, and
a majority of the issued and outstanding stock of the Company and Buyer, have
approved and declared advisable the merger of the Company with and into Buyer
(the "Merger") and approved the Merger upon the terms and subject to the
conditions set forth in this Agreement, whereby each issued and outstanding
share of the common stock of the Company (a "Company Share" or, collectively,
the "Company Shares"), will be converted into 0.1 shares of Series A Convertible
Preferred shares of Buyer and 0.1 shares of Series B Preferred Convertible
Shares of Buyer (together, "Buyer Preferred Stock") which, after giving effect
to the Merger, shall equal, in the aggregate, 2,000,000 shares of Buyer
Preferred Stock and have the right to convert into Common Stock of Buyer
equivalent to 80% and as set forth on Schedule 1 hereto of the total issued and
outstanding common stock of Buyer at the Effective Time (hereinafter defined)
after giving full effect to conversion of Buyer Preferred Stock as described in
SECTION 1.8(c) below, subject to adjustment as specifically provided herein .

     B. The respective Boards of Directors of the Company and Buyer have
determined that the Merger is in furtherance of and consistent with their
respective long-term business strategies and is fair to and in the best
interests of their respective stockholders.

     C. It is intended that, for federal income tax purposes, the Merger shall
qualify as a reorganization under the provisions of Section 368(a) of the
Internal Revenue Code of 1986, as amended, and the rules and regulations
promulgated thereunder (the "Code");

     D. For financial accounting purposes, it is intended that the Merger will
be accounted for as a "purchase".

     NOW, THEREFORE, in consideration of the premises, and of the
representations, warranties, covenants and agreements contained herein, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

                                   ARTICLE I

                      The Merger; Closing; Effect of Merger

     SECTION 1.1 The Merger. Upon the terms and subject to the conditions set
forth in this Agreement and in accordance with Colorado corporate law ("CCL")
and Texas corporate law ("TCL") as amended at the Effective Time, the Company
shall be merged with and into Buyer and the separate corporate existence of the
Company shall thereupon cease. The Buyer shall be the surviving corporation in
the Merger (sometimes hereinafter referred to as the "Surviving Corporation"),

<PAGE>

and the separate corporate existence of Buyer with all its rights, privileges,
immunities, powers and franchises shall continue unaffected by the merger,
except as set forth herein.

     SECTION 1.2 Closing. Subject to the terms and conditions of this Agreement,
the closing of the Merger and the consummation of the other transactions
contemplated hereby (the "Closing") shall take place at the offices of BlueStar
Health Inc. 19901 Southwest Freeway Suite #205-206 Sugar Land, TX 77479 on
March__, 2007 at 10:00 a.m. local time (or at such other date, time and place as
the parties hereto may agree).

     SECTION 1.3 Effective Time. On the date of Closing, the Company and Buyer
will cause a Statement of Merger (the "Statement of Merger") to be executed,
acknowledged and filed with the Colorado Secretary of State and a Certificate of
Merger (the "Certificate of Merger") to be filed with the Texas Secretary of
State. The Merger shall become effective at the time when the Statement of
Merger has been filed with the Colorado Secretary of State, and the Certificate
of Merger has been filed with the Texas Secretary of State, or, as otherwise
agreed by the Company and Buyer (the "Effective Time").

     SECTION 1.4 Articles of Incorporation. The Amended and Restated Articles of
Incorporation of Buyer attached hereto as Exhibit 1.4 shall be the articles of
incorporation of the Surviving Corporation (the "Charter"), until duly amended
as provided therein or by applicable law.

     SECTION 1.5 By-Laws. The by-laws of Buyer in effect immediately prior to
the Effective Time shall be the by-laws of the Surviving Corporation (the
"By-Laws"), until thereafter amended as provided therein or by applicable law.

     SECTION 1.6 Directors. The directors of the Buyer shall, from and after the
Effective Time, be: (i) Naved Jafry (Chairman of the Board); (ii) Richard
Greenwood; (iii) C. Kevin Moore; (iv) Ronald M. Hall; and Wallace J. Rutland.

Officers. The officers of the Buyer shall, from and after the Effective Time,
be: Richard Greenwood (CEO and President), C. Kevin Moore (CFO, Secretary and
Treasurer), and Amir Pirzada (Vice President-Operations).

     SECTION 1.7 Effect on Capital Stock. At the Effective Time, as a result of
the Merger and without any action on the part of the holder of any capital stock
of Buyer:

                 (i) Merger Consideration. Each Company Share issued and
outstanding immediately prior to the Effective Time shall be converted into, and
become exchangeable for 0.1 shares of validly issued, fully paid and
non-assessable shares of Buyer Series A Convertible Preferred Stock and 0.1
shares of Series B Convertible Preferred Stock (together the " Buyer Preferred
Stock " and the "Merger Purchase Price");

                                       2

<PAGE>

                 (ii) Buyer Preferred Stock shall be convertible into Common
Stock as described in SECTION 1.8 below. Each share of Buyer Preferred Stock
shall have voting rights equivalent to the number of shares of Common Stock into
which it is convertible. Should any event described in SECTION 1.8(d) occur
prior to conversion of Buyer Preferred Stock, an equitable adjustment to the
conversion ratio of Buyer Preferred Stock into Buyer Common Stock shall be made.
The full rights and preferences of Buyer Preferred Stock are set forth in
Buyer's Amended and Restated Articles of Incorporation, Exhibit 1.4.

                 (iii) At the Effective Time, all Company Shares shall be
canceled and the Company shall cease to exist, and each share certificate (a
"Certificate") formerly representing any Company Shares shall thereafter
represent only the right to receive the shares of Buyer Preferred Stock into
which such Company Shares have been converted.

     SECTION 1.8 Exchange of Certificates for Shares and Escrow.

           (a) Exchange. At Closing, Buyer shall deliver or cause to be
delivered to each respective owner of Company Shares and in each of their
respective names, certificates representing Series A Preferred Shares into which
the Company Shares that such shareholders owns are to be converted as set forth
on Schedule 1. Pursuant to the Escrow Agreement, a copy of which is attached
hereto as Exhibit 1.8, at Closing, Buyer shall also deliver or cause to be
delivered to escrow number [_________] at ____________________, on behalf of the
respective owners of Company Shares and in each of their respective names,
certificates representing Buyer Series B Preferred Stock into which the Company
Shares that such shareholders owns are to be converted as set forth on Schedule
1 attached hereto.

           (b) Fractional Shares. No certificates or scrip representing
fractional shares of Buyer Preferred Stock shall be issued upon the surrender
for exchange of Certificates pursuant to this Article I; no dividend or other
distribution by Buyer and no stock split, combination or reclassification shall
relate to any such fractional share; and no such fractional share shall entitle
the record or beneficial owner thereof to vote or to any other rights of a
stockholder of Buyer. In lieu of any such factional share, each holder of
Company Shares who would otherwise have been entitled thereto upon the surrender
of Certificate(s) for exchange pursuant to this Article I will be paid one
additional share of Buyer Common Stock.

           (c) Conversion of Preferred Stock. Upon shareholder approval of the
Merger, Amended and Restated Articles of Incorporation changing the Buyer's name
and increasing the number of authorized shares of Buyer Common Stock, each share
of Series A Preferred Stock shall be immediately exchangeable for 40 shares of
Buyer Common Stock. In the event the increased number of common shares is not
approved by shareholders at the time the merger is approved, Series A Preferred
Stock shall be exchangeable into Common Stock at the earliest opportunity
following approval of an increase in the number of authorized common shares
permitting such exchange. Series B Preferred Stock shall be convertible into
43.9165 shares of Buyer Common Stock on the first anniversary of the Effective
Time of the Merger.

                                       3

<PAGE>

           (d) Adjustments of Conversion Number. In the event that Buyer changes
the number of shares of Buyer Common Stock, issued and outstanding prior to the
Effective Time, except as otherwise expressly permitted in this Agreement, as a
result of a reclassification, stock split (including a reverse split), dividend
or distribution, recapitalization, merger (other than the Merger, Stock Purchase
or the cancellation of options previously granted by the Company), subdivision,
or other similar transaction with the effect of increasing or decreasing the
number of shares of Buyer Common Stock, or if a record date with respect to any
of the foregoing shall occur prior to the Effective Time, the conversion number
shall be equitably adjusted.

                                   ARTICLE II

                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company represents, warrants and covenants to Buyer as follows and
acknowledges that Buyer is relying upon such representations and warranties in
connection with the Contemplated Transactions (as hereinafter defined):

     SECTION 2.1 Capitalization. The outstanding and issued capital stock of the
Company consists of 100,000,000 authorized common shares with a par value of:
$0.001. There are 10,000,000 common shares outstanding as detailed on Schedule 1
which sets forth the name of each record and beneficial shareholder of the
Company (each a "Shareholder" and collectively the "Shareholders") and the
number of Company Shares held by each such person. The Company does not and, at
the Closing, the Company will not, have outstanding any capital stock or other
securities or any rights, warrants or options to acquire securities of the
Company or any convertible or exchangeable securities and, other than Buyer
pursuant to this Agreement, no person has or, at Closing will have, any right to
purchase or otherwise acquire any securities of the Company. There are, and at
Closing there will be, no outstanding obligations of the Company to repurchase,
redeem or otherwise acquire any securities of the Company. All of the Company
Shares are, and at Closing will be, duly authorized, duly and validly issued,
fully paid and non-assessable, and none were issued in violation of any
preemptive rights, rights of first refusal or any other contractual or legal
restrictions of any kind except as set forth on Schedule 2.1.

     SECTION 2.2 Title to the Shares. To the best of Company's knowledge and
information each Shareholder is the beneficial owner and holds good and valid
title to its Company Shares free and clear of any Lien. To the best of Company's
knowledge and information, upon consummation of the Contemplated Transactions
and the satisfaction of the conditions to Closing set forth herein, Buyer will
own all of the issued and outstanding shares of capital stock of the Company,
free and clear of any Lien. At the Closing, each Shareholder will deliver the
Company Shares to Buyer free and clear of any Lien, other than restrictions
imposed by the Securities Act of 1933, as amended, and applicable securities
Laws including the laws of the State of Texas.

                                       4

<PAGE>

     SECTION 2.3 Authority Relative to this Agreement. Following approval of the
Shareholders of the Company, the Company will have full power, capacity and
authority to execute and deliver each Transaction Document to which it is or, at
Closing, will be, a party and to consummate the transactions contemplated hereby
and thereby (the "Contemplated Transactions"). The execution, delivery and
performance by the Company of each Transaction Document and the consummation of
the Contemplated Transactions to which the Company is, or at Closing, will be, a
party will have been duly and validly authorized by the Company and no other
acts by or on behalf of the Company will be necessary or required to authorize
the execution, delivery and performance by the Company of each Transaction
Document and the consummation of the Contemplated Transactions to which it is
or, at Closing, will be, a party. This Agreement and the other Transaction
Documents to which the Company is a party have been duly and validly executed
and delivered by the Company and (assuming the valid execution and delivery
thereof by the other parties thereto) will constitute the legal, valid and
binding agreements of the Company enforceable against the Company in accordance
with their respective terms, except as such obligations and their enforceability
may be limited by applicable bankruptcy and other similar Laws affecting the
enforcement of creditors' rights generally and except that the availability of
equitable remedies is subject to the discretion of the court before which any
proceeding therefor may be brought (whether at law or in equity).

     SECTION 2.4 No Conflicts; Consents. The execution, delivery and performance
by the Company of each Transaction Document to which it is a party and the
consummation of the Contemplated Transactions to which the Company is a party,
upon approval of the Shareholders will not: (i) violate any provision of the
certificate of formation or memorandum of association of the Company; (ii)
require the Company to obtain any consent, approval or action of or waiver from,
or make any filing with, or give any notice to, any Governmental Body or any
other person, except as set forth on Schedule 2.4 (the "Company Required
Consents"); (iii) violate, conflict with or result in a breach or default under
(with or without the giving of notice or the passage of time or both), or permit
the suspension or termination of, any material Contract (including any Real
Property Lease) to which the Company is a party or by which it or any of its
assets is bound or subject, or to the best of Company's knowledge and
information result in the creation of any Lien upon any of the Company Shares or
upon any of the Assets of the Company; (iv) violate any Order, any Law, of any
Governmental Body against, or binding upon, the Company or upon any of their
respective assets or the Business; or (v) violate or result in the revocation or
suspension of any Permit.

     SECTION 2.5 Corporate Existence and Power. The Company is a company duly
organized, validly existing and in good standing under the laws of the State of
Texas, and has all requisite powers, authority and all Permits required to own
and/or operate its Assets and to carry on the Business as conducted as of the
date hereof. The Company has no Subsidiaries and does not directly or indirectly
own any equity or other interest or investment in any other person.

     SECTION 2.6 Charter Documents and Corporate Records. The Company has
heretofore delivered to Buyer true and complete copies of the certificate of
formation, bylaws and minute books, or comparable instruments, of the Company as

                                       5

<PAGE>

in effect on the date hereof. The stock transfer books of the Company have been
made available to Buyer for its inspection and are true and complete in all
respects in accordance with their tenor.

     SECTION 2.7 Financial Statements.

           (a) Schedule 2.7A sets forth true, complete and correct copies of:
(i) the Company's reviewed financial statements as of and for the year ended
December 31, 2006 (the "Annual Statement") and (ii) all management letters,
management representation letters and attorney Company Required Consents
response letters issued in connection with the Annual Statement. The Annual
Statement presents fairly and accurately in all material respects the financial
position of the Company as of its date, and the earnings, changes in
stockholders' equity and cash flows thereof for the periods then ended in
accordance with GAAP, consistently applied. Each balance sheet contained therein
or delivered pursuant hereto fully sets forth all consolidated Assets and
Liabilities of the Company existing as of its date which, under GAAP, should be
set forth therein, and each statement of earnings contained therein or delivered
pursuant hereto sets forth the items of income and expense of the Company which
should be set forth therein in accordance with GAAP.

           (b) All financial, business and accounting books, ledgers, accounts
and official and other records relating to the Company have been properly and
accurately kept and completed, and the Company has no knowledge, notice belief
or information there are any material inaccuracies or discrepancies contained or
reflected therein.

     SECTION 2.8 Liabilities. The Company has not incurred any Liabilities since
December 31, 2006 (the "Latest Balance Sheet Date") except (i) current
Liabilities for trade or business obligations incurred in connection with the
purchase of goods or services in the ordinary course of the Business and
consistent with past practice, and (ii) Liabilities reflected on any balance
sheet referred to in Section 2.7(a).

     SECTION 2.9 Company Receivables. Except to the extent of the amount of the
allowance for doubtful accounts reflected in the Annual Statements, all the
Receivables of the Company reflected therein, and all Receivables that have
arisen since the Latest audited Balance Sheet Date (except Receivables that have
been collected since such date), are valid and enforceable Claims subject to no
known defenses, offsets, returns, allowances or credits of any kind, and
constitute bona fide Receivables collectible in the ordinary course of the
Business except as enforceability may be limited by applicable bankruptcy,
reorganization, insolvency, moratorium, fraudulent conveyance or similar laws or
principles of equity affecting the enforcement of creditors rights generally.

     SECTION 2.10 Absence of Certain Changes. (a) Since January 1, 2007 the
Company has conducted the Business in the ordinary course consistent with past
practice, except as disclosed on Schedule 2.10 hereof, and there has not been:

                                       6

<PAGE>

                 (i) Any material adverse change in the Condition of the
Business;

                 (ii) Any damage, destruction or other casualty loss (whether or
not covered by insurance), condemnation or other taking affecting the Business
or the Assets of the Company;

                 (iii) Any change in any method of accounting or accounting
practice by the Company;

                 (iv) Except for normal increases granted in the ordinary course
of business, any increase in the compensation, commission, bonus or other direct
or indirect remuneration paid, payable or to become payable to any officer,
stockholder, director, consultant, agent or employee of the Company, or any
alteration in the benefits payable or provided to any thereof;

                 (v) Any material adverse change in the relationship of the
Company with its employees, customers, suppliers or vendors;

                 (vi) Except for any changes made in the ordinary course of
Business, any material change in any of the Company's business policies,
including advertising, marketing, selling, pricing, purchasing, personnel,
returns or budget policies;

                 (vii) Any agreement or arrangement whether written or oral to
do any of the foregoing.

                 (viii) The Company has no Liability that is past due except as
shown on the Annual Statements.

     SECTION 2.11 Leased Real Property. (a) The Company has no fee interest,
purchase options or rights of first refusal in any real property and the Company
has no leasehold or other interest in any real property, except as set forth on
Schedule 2.11 (the "Leased Real Property"), and all leases including all
amendments, modifications, extensions, renewals and/or supplements thereto
(collectively, "Real Property Leases") are described on Schedule 2.11.

     SECTION 2.12 Personal Property; Assets. The Company has good and valid
title to (or valid leasehold interest in) all of its personal property and
Assets, free and clear of all Liens, except the Permitted Liens and as indicated
on Schedule 2.12. The machinery, equipment, computer software and other tangible
personal property constituting part of the Assets and all other Assets (whether
owned or leased) are in good condition and repair (subject to normal wear and
tear) and are reasonably sufficient and adequate in quantity and quality for the
operation of the Business as previously and presently conducted. Schedule 2.12
contains a list and description of all tangible personal property owned or

                                       7

<PAGE>

leased by the Company with a book value (before depreciation) of $5,000 or more.
The Assets constitute all of the assets, which are necessary to operate the
Business of the Company as currently conducted.

     SECTION 2.13 Contracts. (a) Schedule 2.13 sets forth an accurate and
complete list of all Contracts to which the Company is a party or by which it or
its Assets are bound or subject that: (i) cannot be canceled upon 30 days'
notice without the payment or penalty of less than One Thousand Dollars
($1,000); or (ii) involve aggregate annual future payments by or to any person
of more than Five Thousand Dollars ($5,000). True and complete copies of all
written Contracts (including all amendments thereto and waivers in respect
thereof) and summaries of the material provisions of all oral Contracts so
listed have been made available to Buyer.

           (b) All Contracts to which the Company is a party are valid,
subsisting, in full force and effect and binding upon the Company and the other
parties thereto, in accordance with their terms, except that no representation
or warranty is given as to the enforceability of any oral Contracts. To the best
of the Company's knowledge and belief, except as set forth on Schedule 2.13, the
Company is not in default (or alleged default) under any such Contract.

           (c) The contracts between Company and Safe Fuel and Star Fuel, true
and accurate copies of which are appended to Schedule 2.13, are in full force
and effect, with no defaults existing on the part of either party to the
contract. Also appended to Schedule 2.13 are written consents of Safe Fuel and
Star Fuel to the merger of the Company into Buyer and assumption of the
contracts by Buyer.

     SECTION 2.14 Patents and Intellectual Property Rights. (a) Schedule 2.14
sets forth a list of each patent, trademark, trade name, service mark, brand
mark, brand name, and registered copyright as well as all registrations thereof
and pending applications therefore, and each license or other contract relating
thereto (collectively, the "Intellectual Property") owned or used in connection
with the Business by the Company and indicates, with respect to each item of
Company's Intellectual Property that is licensed by the Company, the name of the
licensor thereof and, with respect to oral Contracts, the terms of such license
relating thereto. To the Company's knowledge, the use of the foregoing by the
Company does not conflict with, infringe upon, violate or interfere with or
constitute an appropriation of any right, title, interest or goodwill,
including, without limitation, any intellectual property right, patent,
trademark, trade name, service mark, brand name, computer program, database,
industrial design, trade secret, copyright or any pending application thereto of
any other person and there have been no claims made and the Company has not
received any notice or otherwise know that any of the foregoing is invalid or
conflicts with the asserted rights of other Persons or have not been used or
enforced or have been failed to be used or enforced in a manner that would
result in the abandonment, cancellation or unenforceability of the Intellectual
Property, except as set forth on Schedule 2.14A.

           (b) The Company owns or has rights to use all Intellectual Property,
know-how, formulae and other proprietary and trade rights necessary to conduct

                                       8

<PAGE>

the Business as it is now conducted. The Company has not forfeited or otherwise
relinquished any such Intellectual Property, know-how, formulae or other
proprietary right used in the conduct of the Business as now conducted.

           (c) To the extent used in the conduct of the Business by the Company,
each of the licenses or other contracts relating to the Company's Intellectual
Property (collectively, the "Intellectual Property Licenses") is in full force
and effect and is valid and enforceable in accordance with its terms, subject to
applicable bankruptcy, insolvency, reorganization, moratorium and similar laws
affecting creditors' rights and remedies generally, and subject, as to
enforceability, to general principles of equity (regardless of whether
enforcement is sought in a proceeding at law or in equity), and there is no
notice or claim of default under any Intellectual Property License either by the
Company or, to the Company's knowledge, by any other party thereto, and to the
Company's knowledge, no event has occurred that with the lapse of time or the
giving of notice or both would constitute a default by the Company there under.

     SECTION 2.15 Claims and Proceedings. There are no outstanding Orders of any
Governmental Body against or involving the Company, its Assets, the Business, or
the Company Shares. There are no actions, suits, claims or counterclaims,
examinations, Company Required Consents or legal, administrative, governmental
or arbitral proceedings or investigations (collectively, "Claims") (whether or
not the defense thereof or Liabilities in respect thereof are covered by
insurance), pending or, to the best of the Company's knowledge, threatened on
the date hereof, against or involving the Company, its Assets, the Business or
the Company Shares.

     SECTION 2.16 Taxes. (a) Except as set forth in Schedule 2.16:

                 (i) The Company has timely filed or, if not yet due but due
before Closing, will timely file all Tax Returns required to be filed by it for
all taxable periods ending on or before the date of Closing and all such Tax
Returns are or, if not yet filed, will be, upon filing, true, correct and
complete in all material respects;

                 (ii) the Company has paid, or if payment is not yet due but due
before Closing, will promptly pay when due to each appropriate Tax Authority,
all Taxes of the Company shown as due on the Tax Returns required to be filed by
it for all taxable periods ending on or before the date of Closing;

                 (iii) the accruals for Taxes currently payable as well as for
deferred Taxes shown on the financial statements of the Company as of the date
of the Annual Statement or the date of any financial statements delivered
hereunder: (A) adequately provide for all contingent Tax Liabilities of the
Company as of the date thereof; and (B) accurately reflect, as of the date
thereof, all unpaid Taxes of the Company whether or not disputed, in each case
as required to be reflected thereon in order for such statements to be in
accordance with GAAP;

                                       9

<PAGE>

                 (iv) no extension of time has been requested or granted for the
Company to file any Tax Return that has not yet been filed or to pay any Tax
that has not yet been paid and the Company has not granted a power of attorney
that remains outstanding with regard to any Tax matter;

                 (v) the Company has not received notice of a determination by a
Tax Authority that Taxes are currently owed by the Company (such determination
to be referred to as a "Tax Deficiency") and, to the Company's knowledge, no Tax
Deficiency is proposed or threatened;

                 (vi) all Tax Deficiencies have been paid or finally settled and
all amounts determined by settlement to be owed have been paid;

                 (vii) there are no Tax Liens on or pending against the Company
or any of the Assets, other than those which constitute Permitted Liens;

                 (viii) there are no presently outstanding waivers or extensions
or requests for a waiver or extension of the time within which a Tax Deficiency
may be asserted or assessed;

                 (ix) no issue has been raised in any examination,
investigation, Company Required Consents, suit, action, claim or proceeding
relating to Taxes (a "Tax Company Required Consents") which, by application of
similar principles to any past, present or future period, would result in a Tax
Deficiency for such period;

                 (x) there are no pending or threatened Tax Audits of the
Company;

                 (xi) the Company has no deferred intercompany gains or losses
that have not been fully taken into income for income Tax purposes;

                 (xii) there are no transfer or other taxes (other than income
taxes) imposed by any state on the Company by virtue of the Contemplated
Transactions; and

                 (xiii) no claim has been made by any Tax Authority that the
Company is subject to Tax in a jurisdiction in which the Company is not then
paying Tax of the type asserted.

Each reference to a provision of the Code in this Section 2.16 shall be treated
for state and local Tax purposes as a reference to analogous or similar
provisions of state and local law.

           (b) To the Company's knowledge, the Company has collected and
remitted to the appropriate Tax Authority all sales and use or similar Taxes
required to be collected on or prior to the date of Closing and has been
furnished properly completed exemption certificates for all exempt transactions

                                       10

<PAGE>

and has no information otherwise or notice of any claim by any government or
jurisdiction with regards thereto. The Company has maintained and has in its
possession all records, supporting documents and exemption certificates required
by applicable sales and use Tax statutes and regulations to be retained in
connection with the collection and remittance of sales and use Taxes for all
periods up to and including the date of Closing. With respect to sales made by
the Company prior to the date of Closing for which sales and use Taxes are not
yet due as of the date of Closing, all applicable sales and use Taxes payable
with respect to such sales will have been collected or billed by the Company and
will be included in the Assets of the Company as of the date of Closing.

     SECTION 2.17 Compliance with Laws. The Company is not in violation of any
order, judgment, injunction, award, citation, decree, consent decree or writ
(collectively, "Orders") and to the best of the Company's knowledge, belief and
information, any Laws of any Governmental Bodies affecting the Company, the
Company Shares or the Business.

     SECTION 2.18 Permits. The Company has obtained all licenses, permits,
certificates, certificates of occupancy, orders, authorizations and approvals
(collectively, "Permits"), and has made all required registrations and filings
with all Governmental Bodies, that are necessary to the ownership of the Assets,
the use and occupancy of the Leased Real Property, as presently used and
operated, and the conduct of the Business or otherwise required to be obtained
by the Company. All Permits required to be obtained or maintained by the Company
are listed on Schedule 2.18 and are in full force and effect; no violations are
or have been recorded, nor have any notices or violations thereof been received,
in respect of any Permit; and no proceeding is pending or threatened to revoke
or limit any Permit; and the consummation of the Contemplated Transactions will
not (or with the giving of notice or the passage of time or both will not) cause
any Permit to be revoked or limited.

     SECTION 2.19 Environmental Matters. To the best of the Company's knowledge,
belief and information, the Company is, and at all times has been, in full
compliance with, and has not been and is not in violation of or liable under,
any Environmental Law.

     SECTION 2.20 Finders Fees. Other than as set forth in Schedule 2.20, there
is no investment banker, broker, finder or other intermediary which has been
retained by or is authorized to act on behalf of the Company who might be
entitled to any fee or commission from the Company in connection with the
consummation of the Contemplated Transactions. Any finder's fees shall be paid
by Company's shareholders.

     SECTION 2.21 Disclosure. Neither this Agreement, the Schedules hereto, nor
any reviewed or unaudited financial statements, documents or certificates
furnished or to be furnished to Buyer by or on behalf of the Company pursuant to
this Agreement contains or will contain any untrue statement of a material fact
or omits or will omit to state a material fact necessary in order to make the
statements contained herein or therein not misleading. There are no events,
transactions or other facts, which, either individually or in the aggregate, may
give rise to circumstances or conditions which would have a material adverse
effect on the general affairs or Condition of the Business.

                                       11

<PAGE>

     SECTION 2.22 Business Contracts. The Company has (i) entered into contracts
for supply of its basic goods and material sufficient to fulfill contracts for
sale of its basic products such that (ii) its retail delivery contract(s) will
result in the sale of 800,000 gallons of its basic product each month for a
period of at least one year. The Company believes the underlying contracts are
binding upon the counter-parties and the counter-parties from the Company's due
diligence are financially capable of completing the terms of the respective
contracts.

                                  ARTICLE III

                     REPRESENTATIONS AND WARRANTIES OF BUYER

     Buyer represents, warrants and covenants to the Company as follows and
acknowledge that the Company is relying upon such representations and warranties
in connection with the Contemplated Transactions:

     SECTION 3.1 Authority Relative to this Agreement. Buyer has full power and
authority to execute and deliver each Transaction Documents to which they are
or, at Closing, will be, a party and to consummate the Contemplated
Transactions. Following the approval of the board of directors of Buyer and the
shareholders of the Buyer with respect to the Contemplated Transactions, the
execution, delivery and performance by Buyer of each Transaction Document and
the consummation of the Contemplated Transactions to which they are or, at
Closing, will be, a party have been duly and validly authorized and approved by
Buyer and no other acts by or on behalf of Buyer is necessary or required to
authorize the execution, delivery and performance by Buyer of each Transaction
Document and the consummation of the Contemplated Transactions to which they are
or, at Closing, will be a party. This Agreement and the other Transaction
Documents to which Buyer is a party have been, duly and validly executed and
delivered by Buyer and (assuming the valid execution and delivery thereof by the
other parties thereto) constitutes, or will, at the Closing, constitute, as the
case may be, the legal, valid and binding agreements of Buyer enforceable
against each of them in accordance with their respective terms, except as such
obligations and their enforceability may be limited by applicable bankruptcy and
other similar Laws affecting the enforcement of creditors' rights generally and
except that the availability of equitable remedies is subject to the discretion
of the court before which any proceeding therefor may be brought (whether at law
or in equity).

     SECTION 3.2 No Conflicts; Consents. The execution, delivery and performance
by Buyer of each Transaction Document to which it is a party and the
consummation of the Contemplated Transactions to which Buyer is a party does not
and will not: (i) violate any provision of the certificate of incorporation or
by-laws of Buyer, as the case may be; (ii) require Buyer to obtain any consent,
approval or action of or waiver from, or make any filing with, or give any
notice to, any Governmental Body or any other person, except as set forth on
Schedule 3.2 (the "Buyer Required Consents"); (iii) except as set forth in
Schedule 3.2, violate, conflict with or result in the breach or default under
(with or without the giving of notice or the passage of time), or permit the
suspension or termination of, any material Contract to which Buyer is a party or
any of them or any of their assets is bound or subject or result in the creation
or any Lien upon any of Buyer Common Stock or upon any assets of Buyer; or (iv)

                                       12

<PAGE>

violate any Order or, to Buyer's knowledge, any Law of any Governmental Body
against, or binding upon Buyer, or upon any of their respective assets or
businesses.

     SECTION 3.3 Corporate Existence and Power of Buyer. Buyer is a corporation
duly organized, validly existing and in good standing under the laws of the
State of Colorado, and has all requisite corporate powers and all material
governmental licenses, authorizations, consents and approvals required to carry
on its business as now conducted. Other than the execution of this Agreement,
Buyer has not conducted any business of any nature.

     SECTION 3.4 The Buyer Common Stock. At the Closing, the Buyer Common Stock
will have been duly authorized by Buyer and, when issued to Shareholders
pursuant to this Agreement, will be duly issued, fully paid and non-assessable
shares of Buyer Common Stock. The Buyer Common Stock, when issued pursuant
hereto: (i) will not be issued in violation of or subject to any preemptive
rights, rights of first refusal or, other than as set forth in this Agreement,
contractual restrictions of any kind; and (ii) will vest in Shareholders,
respectively, good title to Buyer Common Stock free and clear of all Liens.

     SECTION 3.5 Capitalization. The authorized capital stock of Buyer consists
of: (i) 40,000,000 shares of common stock, $0.001 par value; and, (ii)
10,000,000 shares of preferred stock, no stated par value. Buyer has; (i)
14,000,504 shares of common stock; and (ii) no shares of preferred stock; (iii)
no more than 6,978,616 shares of common stock will be issued to satisfy shares
in exchange of debt, issued and outstanding and at the Closing, Buyer will not,
have outstanding any capital stock or other securities or any rights, warrants
or options to acquire securities of Buyer or any convertible or exchangeable
securities and, other than Buyer pursuant to this Agreement, no person has or,
at Closing will have, any right to purchase or otherwise acquire any securities
of Buyer. There are, and at Closing there will be, no outstanding obligations of
Buyer to repurchase, redeem or otherwise acquire any securities of Buyer. All of
Buyer Common Stock at Closing will be, duly authorized, duly and validly issued
of proper filings will have been submitted with the appropriate state and
federal agencies, fully paid and non-assessable, and none were issued in
violation of any preemptive rights, rights of first refusal or any other
contractual or legal restrictions of any kind.

     SECTION 3.6 Disclosure of Information. Buyer has been given the
opportunity: (i) to ask questions of, and to receive answers from, persons
acting on behalf of the Company concerning the terms and conditions of the
Contemplated Transactions and the business, properties, prospects and financial
conditions of the Company; and (ii) to obtain any additional information (to the
extent the Company or any of the Shareholders possesses such information or is
able to acquire it without unreasonable effort or expense and without breach of
confidentiality obligations) necessary to verify the accuracy of information
provided about the Company.

     SECTION 3.7 SEC Filings. Buyer has or will have filed with the SEC all
forms, reports, schedules, and statements that were required to be filed by it
with the SEC within the three (3) year period ending on the Effective Time, and
previously has furnished or made available to the Company accurate and complete
copies of all the SEC Documents. As of their respective dates, the SEC Documents

                                       13

<PAGE>

were and will be prepared in accordance with the Exchange Act and the Securities
Act and did not contain any untrue statement of a material fact or omit to state
a material fact required to be stated in those documents or necessary to make
the statements in those documents not misleading, in light of the circumstances
under which they were made. As of their respective dates, these reports and
statements will not contain any untrue statement of a material fact or omit to
state a material fact required to be stated in them or necessary to make the
statements in them not misleading, in light of the circumstances under which
they are made and these reports and statements will comply in all material
respects with all applicable requirements of the Exchange Act and the Securities
Act.

     SECTION 3.8 Financial Statements. The audited consolidated financial
statements and unaudited consolidated interim financial statements of Buyer that
are included or incorporated in the SEC Documents were and will be prepared in
accordance with GAAP applied on a consistent basis during the periods involved
(except as otherwise indicated in the notes to them) and fairly present the
consolidated financial position, results of operations, and cash flows from
operating, investing, and financing activities of Buyer as of the dates and for
the periods indicated, except that the unaudited consolidated interim financial
statements in the SEC Documents are subject to normal year-end adjustments and
were prepared in accordance with the instructions to SEC Form 10-QSB and,
accordingly, omit or condense certain footnotes and other information normally
included in financial statements prepared in accordance with GAAP. The
consolidated financial statements of Buyer that are included or incorporated in
any subsequent report or statement that Buyer mails to its shareholders
generally or files with the SEC during the period after the date of this
Agreement and before the Closing Date will be prepared in accordance with GAAP
applied on a consistent basis during the periods involved (except as otherwise
indicated in them, the notes to them, or any related report of Buyer's
independent accountants) and will fairly present the financial information that
they purport to present, except that the unaudited, consolidated interim
financial statements will be subject to normal year-end adjustments and will
omit or condense certain footnotes and other information normally included in
financial statements prepared in accordance with GAAP.

     SECTION 3.9 Charter Documents and Corporate Records. Buyer has heretofore
delivered to the Company true and complete copies of the articles of
incorporation, by-laws and minute books, or comparable instruments, of Buyer as
in effect on the date hereof. The stock transfer books of Buyer have been made
available to the Company for its inspection and are true and complete in all
respects.

     SECTION 3.10 Liabilities. Except as set forth on Schedule 3.10, Buyer has
not incurred any Liabilities since December 31, 2006 except those incurred in
the ordinary course of business which have been discharged.

     SECTION 3.11 Absence of Certain Changes. (a) Since December 31, 2006, Buyer
has conducted its business in the consistent with past practice and except as
disclosed on Schedule 3.11 hereto there has not been:

                                       14

<PAGE>

                 (i) Any change in any method of accounting or accounting
practice by Buyer;

                 (ii) Any increase in the compensation, commission, bonus or
other direct or indirect remuneration paid, payable or to become payable to any
officer, stockholder, director, consultant, agent or employee of Buyer, or any
alteration in the benefits payable or provided to any thereof;

                 (iii) Any material adverse change in the relationship of Buyer
with its employees, customers, suppliers or vendors;

                 (iv) Except for any changes made in the ordinary course of
business, any material change in any of Buyer 's business policies, including
advertising, marketing, selling, pricing, purchasing, personnel, returns or
budget policies;

                 (v) Any agreement or arrangement whether written or oral to do
any of the foregoing; and

                 (vi) Buyer has no Liability that is past due except as shown on
the financial statements as filed with the SEC.

     SECTION 3.12 Contracts. (a) Schedule 3.12 sets forth an accurate and
complete list of all Contracts to which Buyer is a party or by which it or its
assets are bound or subject that: (i) cannot be canceled upon 30 days' notice
without the payment or penalty of less than One Thousand Dollars ($1,000); or
(ii) involve aggregate annual future payments by or to any person of more than
Five Thousand Dollars ($5,000). True and complete copies of all written
Contracts (including all amendments thereto and waivers in respect thereof) and
summaries of the material provisions of all oral Contracts so listed have been
made available to the Company.

           (b) All Contracts to which Buyer is a party are valid, subsisting, in
full force and effect and binding upon Buyer and the other parties thereto, in
accordance with their terms, except that no representation or warranty is given
as to the enforceability of any oral Contracts. To the best of Buyer's knowledge
and belief, except as set forth on Schedule 3.12, Buyer is not in default (or
alleged default) under any such Contract.

     SECTION 3.13 Claims and Proceedings. There are no outstanding Orders of any
Governmental Body against or involving Buyer, its assets or its business. There
are no Claims (whether or not the defense thereof or Liabilities in respect
thereof are covered by insurance), pending or, to the best of Buyer 's
knowledge, threatened on the date hereof, against or involving Buyer, its assets
or its business.

                                       15

<PAGE>

     SECTION 3.14 Taxes. Except as set forth on Schedule 3.14:

           (a)

                 (i) Buyer has filed or, if not yet due but due before Closing,
will timely file all Tax Returns required to be filed by it for all taxable
periods ending on or before the date of Closing and all such Tax Returns are or,
if not yet filed, will be, upon filing, true, correct and complete in all
material respects;

                 (ii) Buyer has paid, or if payment is not yet due but due
before Closing, will promptly pay when due to each appropriate Tax Authority,
all Taxes of Buyer shown as due on the Tax Returns required to be filed by it
for all taxable periods ending on or before the date of Closing;

                 (iii) the accruals for Taxes currently payable as well as for
deferred Taxes shown on the financial statements of Buyer as of the date of the
Interim Statements or the date of any financial statements delivered hereunder:
(A) adequately provide for all contingent Tax Liabilities of Buyer as of the
date thereof; and (B) accurately reflect, as of the date thereof, all unpaid
Taxes of Buyer whether or not disputed, in each case as required to be reflected
thereon in order for such statements to be in accordance with GAAP;

                 (iv) no extension of time has been requested or granted for
Buyer to file any Tax Return that has not yet been filed or to pay any Tax that
has not yet been paid and Buyer has not granted a power of attorney that remains
outstanding with regard to any Tax matter;

                 (v) Buyer has not received notice of a Tax Deficiency and, to
Buyer 's knowledge, no Tax Deficiency is proposed or threatened;

                 (vi) all Tax Deficiencies have been paid or finally settled and
all amounts determined by settlement to be owed have been paid;

                 (vii) there are no Tax Liens on or pending against Buyer or any
of the assets, other than those which constitute Permitted Liens;

                 (viii) there are no presently outstanding waivers or extensions
or requests for a waiver or extension of the time within which a Tax Deficiency
may be asserted or assessed;

                 (ix) no issue has been raised in any examination,
investigation, suit, action, claim or proceeding relating to Taxes which, by
application of similar principles to any past, present or future period, would
result in a Tax Deficiency for such period;

                                       16

<PAGE>

                 (x) there are no pending or threatened Tax Audits of Buyer;

                 (xi) Buyer has no deferred inter-company gains or losses that
have not been fully taken into income for income Tax purposes;

                 (xii) there are no transfer or other taxes (other than income
taxes) imposed by any state on Buyer by virtue of the Contemplated Transactions;
and

                 (xiii) no claim has been made by any Tax Authority that Buyer
is subject to Tax in a jurisdiction in which Buyer is not then paying Tax of the
type asserted.

Each reference to a provision of the Code in this Section 3.16 shall be treated
for state and local Tax purposes as a reference to analogous or similar
provisions of state and local law.

           (b) To Buyer's knowledge, Buyer has collected and remitted to the
appropriate Tax Authority all sales and use or similar Taxes required to be
collected on or prior to the date of Closing and has been furnished properly
completed exemption certificates for all exempt transactions and has no
information otherwise or notice of any claim by any government or jurisdiction
with regards thereto. Buyer has maintained and has in its possession all
records, supporting documents and exemption certificates required by applicable
sales and use Tax statutes and regulations to be retained in connection with the
collection and remittance of sales and use Taxes for all periods up to and
including the date of Closing. With respect to sales made by Buyer prior to the
date of Closing for which sales and use Taxes are not yet due as of the date of
Closing, all applicable sales and use Taxes payable with respect to such sales
will have been collected or billed by Buyer and will be included in the assets
of Buyer as of the date of Closing.

     SECTION 3.15 Compliance with Laws. Buyer is not in violation of any Orders
and to the best of Buyer's knowledge, belief and information, any Laws of any
Governmental Bodies affecting Buyer or the Buyer Common Stock except as are set
forth on Schedule 3.15.

     SECTION 3.16 Environmental Matters. To the best of Buyer's knowledge,
belief and information, Buyer is, and at all times has been, in full compliance
with, and has not been and is not in violation of or liable under, any
Environmental Law.

     SECTION 3.17 Finders Fees. There is no investment banker, broker, finder or
other intermediary which has been retained by or is authorized to act on behalf
of Buyer who might be entitled to any fee or commission from Buyer in connection
with the consummation of the Contemplated Transactions.

                                       17

<PAGE>

                                   ARTICLE IV

                            COVENANTS AND AGREEMENTS

     SECTION 4.1 The Company covenants to Buyer and Buyer covenants to the
Company that:

           (a) Filings and Authorizations. The parties hereto shall cooperate
and use their respective best efforts to make, or cause to be made, all
registrations, filings, applications and submissions, to give all notices and to
obtain all governmental or other third party consents, transfers, approvals,
Orders and waivers necessary or desirable for the consummation of the
Contemplated Transactions in accordance with the terms of this Agreement
including without limitation the preparation of any SEC Documents required to be
filed with the SEC by Buyer which are required by the securities laws generally
or in connection with the transactions contemplated by this Agreement; and shall
furnish copies thereof to each other party prior to such filing and shall not
make any such registration, filing, application or submission to which Buyer or
the Company, as the case may be, reasonably objects in writing. All such filings
shall comply in form and content in all material respects with applicable Law.
The parties hereto also agree to furnish each other with copies of such filings
and any correspondence received from any Governmental Body in connection
therewith.

           (b) Buyer's Shareholder Approvals. Buyer shall solicit approval from
Buyer's shareholders through a Proxy in accordance with all SEC and Colorado
requirements that would authorize by majority vote:

                 (i) the Merger described herein;

                 (ii) the increase in authorized common shares to 200,000,000
                 shares;

                 (iii) the adoption of the Amended and Restated Articles of
                 Incorporation of Buyer;

                 (iv) the change of Buyer's name from BlueStar Health, Inc. to
                 Zeon Fuels, Inc.;

           (c) NASD Move. Buyer shall petition to move the stock of the Buyer
currently listed on the NASD "Pink Sheets" to the NASD "Over the Counter
Bulletin Board" market, or such other recognized stock exchange as Buyer and
Company shall select, and petition to change the stock symbol to ZEON or such
other symbol acceptable to the Company should ZEON not be approved.

                                       18

<PAGE>

     SECTION 4.2 Confidentiality. Each party hereto shall hold in strict
confidence, and shall use its best efforts to cause all of its officers,
employees, agents and professional counsel and accountants, (collectively,
"Representatives") to hold in strict confidence, unless compelled to disclose by
judicial or administrative process, or by other requirements of Law, all
information concerning any other party which it has obtained from such party
prior to, on, or after the date hereof in connection with the Contemplated
Transactions, and each party shall not use or disclose to others, or permit the
use of or disclosure of, any such information so obtained, and will not release
or disclose such information to any other person, except its Representatives who
need to know such information in connection with this Agreement and who shall be
advised of the provisions of this Section 4.2. The foregoing provision shall not
apply to any such information to the extent; (i) known by any party prior to the
date such information was provided to such party in connection with the
Contemplated Transactions; (ii) made known to such party from a third party not
in breach of any confidentiality requirement; or (iii) made public through no
fault of such party or any of its Representatives.

     SECTION 4.3 Expenses. Buyer and the Company (for itself and on behalf of
each Shareholder) shall bear their respective expenses, in each case, incurred
in connection with the preparation, execution and performance of the Transaction
Documents and the Contemplated Transactions, including, without limitation, all
fees and expenses of their respective Representatives, and the Company shall
bear all the fees and expenses of any Company's Representatives.

     SECTION 4.4 Buyer Compliance Costs. The Company commits to provide Buyer up
to $75,000 from any new capital raised from the date of the signing of this
Agreement to fund costs associated with Buyer's completion of the audit of its
financial accounting records and the preparation and filing of reports to become
current with its SEC filings. The Company shall advance the funds promptly after
receiving funds raised in this regard to Buyer, but in no event longer than ten
days after receiving good available funds.

     SECTION 4.5 Tax Matters. The Company and Buyer shall reasonably cooperate,
and shall cause their respective Representatives reasonably to cooperate, in
preparing and filing all Tax Returns, including maintaining and making available
to each other all records necessary in connection with the preparation and
filing of Tax Returns, the payment of Taxes and the resolution of Tax Audits and
Tax Deficiencies with respect to all taxable periods. Refunds or credits of
Taxes that were paid by the Company with respect to any periods shall be for the
account of the Company.

     SECTION 4.6 Further Assurances. At any time and from time to time after the
date of Closing, upon the reasonable request of any party hereto, the other
party(ies), shall do, execute, acknowledge and deliver, or cause to be done,
executed, acknowledged or delivered, all such further documents, instruments or
assurances, as may be necessary, desirable or proper to carry out the intent and
accomplish the purposes of this Agreement.

     SECTION 4.7 Restricted Securities. The parties acknowledge and agree that
the Company Shares and Buyer Common Stock being issued or transferred pursuant
to the Contemplated Transactions are being issued or transferred pursuant to the

                                       19

<PAGE>

exemption from the registration requirements of the Securities Act of 1933, as
amended (the "Securities Act") and constitute "restricted securities" within the
meaning of the Securities Act. Such securities may not be transferred absent
compliance with the provisions of the Securities Act, other applicable Laws, and
all stock certificates evidencing such securities shall bear a legend to such
effect and to the effect that such shares are subject to the terms and
provisions of this Agreement; provided, however, that it is anticipated that for
purposes of Rule 144 of the Securities Act, that the holding period of Buyer
Common Stock for each shareholder of the Company shall be determined to commence
on the date of acquisition of the Company Shares (as converted pursuant to this
Agreement) for each such respective holder.

     SECTION 4.8 Due Diligence. Prior to the Closing Date, Buyer agrees that the
Company shall be entitled, through its Representatives, to make such
investigation of the properties, businesses and operations of Buyer, and such
examination of the books, records and financial condition of Buyer, as the
Company reasonably deems necessary. Any such investigation and examination shall
be conducted at reasonable times, under reasonable circumstances and upon
reasonable notice. No investigation by Buyer shall diminish or obviate any of
the representations, warranties, covenants or agreements of Buyer contained in
this Agreement.

                                   ARTICLE V

                              CONDITIONS TO CLOSING

     SECTION 5.1 Conditions to the Obligations of the Parties. The obligations
of the Parties to consummate the Contemplated Transactions are subject to the
satisfaction of the following conditions:

           (a) Liabilities of the Buyer. The aggregate Liabilities of the Buyer
shall not exceed $700,000.

           (b) No Injunction. No provision of any applicable Law and no Order
shall prohibit the consummation of the Contemplated Transactions.

           (c) No Proceedings or Litigation. No Claim instituted by any person
(other than Buyer, the Company, Shareholders or their respective Affiliates)
shall have been commenced or pending against any Shareholder, the Company, Buyer
or any of their respective Affiliates, officers or directors, which Claim seeks
to restrain, prevent, change or delay in any respect the Contemplated
Transactions or seeks to challenge any of the terms or provisions of this
Agreement or seeks damages in connection with any of such transactions.

           (d) Buyer Consents. Buyer shall have successfully obtained the
consents, approvals or taken the other actions described in Article IV, Section
4.1(b) and Section 4.1(c).

                                       20

<PAGE>

     SECTION 5.2 Conditions to the Obligations of the Company. The obligations
of the Company hereunder to consummate the Contemplated Transactions are
subject, at the option of the Company, to the fulfillment prior to or at the
Closing of each of the following further conditions:

           (a) Performance. Buyer shall have performed and complied in all
material respects with all agreements, obligations and covenants required by
this Agreement to be performed or complied with by it at or prior to the Closing
Date.

           (b) Representations and Warranties. The representations and
warranties of Buyer contained in this Agreement and in any certificate or other
writing delivered by Buyer pursuant hereto shall be true in all material
respects at and as of the Closing Date as if made at and as of such time (except
for those representations and warranties made as of a specific date which shall
be true in all material respects as of the date made).

           (c) No Material Adverse Change. From the date hereof through the
Closing, there shall not have occurred any event or condition that has had or
could have a material adverse effect on Buyer.

           (d) Documentation. There shall have been delivered to the Company the
following:

                 (i) A certificate, dated the Closing Date, of the Chairman of
the Board and the President of Buyer confirming the matters set forth in Section
5.2(a) (b) and (c) hereof;

                 (ii) Buyer Common Stock certificates, registered in the name of
each Shareholder as set forth on Schedule 1 attached hereto, (with the
appropriate restrictive legends as applicable), evidencing satisfaction of the
Purchase Price in accordance with Section 1.8;

                 (iii) Certificate of Merger;

                 (iv) Statement of Merger;

                 (v) Escrow Agreement; and

                 (vi) The Amended and Restated Articles of Incorporation as
filed with the Secretary of State of the State of Colorado

     SECTION 5.3 Conditions to the Obligations of Buyer. All obligations of
Buyer to consummate the Contemplated Transactions hereunder are subject, at the
option of Buyer, to the fulfillment prior to or at the Closing of each of the
following further conditions:

                                       21

<PAGE>

           (a) Performance. The Company shall have performed and complied in all
material respects with all agreements, obligations and covenants required by
this Agreement to be performed or complied with by them at or prior to the
Closing Date.

           (b) Representations and Warranties. The representations and
warranties of the Company, contained in this Agreement and in any certificate or
other writing delivered by the Company pursuant hereto shall be true in all
material respects at and as of the Closing Date as if made at and as of such
time (except for those representations and warranties made as of a specific date
which shall be true in all material respects as of the date made).

           (c) No Material Adverse Change. From the date hereof through the
Closing, there shall not have occurred any event or condition that has had or
could have a material adverse effect on the Company.

           (d) Documentation. There shall have been delivered to Buyer the
following:

                 (i) A certificate, dated the Closing Date, of the Chairman of
the Board, the President or Chief Financial Officer of the Company confirming
the matters set forth in Section 5.3(a) (b) and (c) hereof;

                 (ii) A certificate, dated the Closing Date, of the Secretary of
the Company certifying, among other things, that attached or appended to such
certificate: (i) is a true and correct copy of the Company's certificate of
incorporation and all amendments thereto, if any, as of the date thereof
certified by the Texas Secretary of State; and (ii) is a true and correct copy
of the Company's memorandum of association as of the date thereof;

                 (iii) Certificate of Merger;

                 (iv) Statement of Merger;

                 (v) Escrow Agreement;

                 (vi) The Amended and Restated Articles of Incorporation of
Buyer as filed with the Secretary of State of the State of Colorado;

                 (vii) Company Share certificates representing the number of
Company Shares duly endorsed in blank or accompanied by stock powers duly
endorsed in blank and in suitable form for transfer to Buyer by delivery;

                 (viii) Company will pay certain Costs. Company shall have
advanced up to $75,000 in accordance with the provision described in Section 4.4
hereof; and

                                       22

<PAGE>

                 (ix) The Company has obtained the written consents for
assignment to and assumption by Buyer, of the contracts described in Section
2.13(c).

                                   ARTICLE VI

                                 INDEMNIFICATION

     SECTION 6.1 Survival of Representations, Warranties and Covenants.

           (a) Notwithstanding any right of Buyer fully to investigate the
affairs of the Company and the rights of the Company to fully investigate the
affairs of Buyer, and notwithstanding any knowledge of facts determined or
determinable by Buyer, or the Company, pursuant to such investigation or right
of investigation, Buyer, and the Company, have the right to rely fully upon the
representations, warranties, covenants and agreements of the Company, and Buyer
respectively, contained in this Agreement, or listed or disclosed on any
Schedule or Exhibit hereto or in any instrument delivered in connection with or
pursuant to any of the foregoing. All such representations, warranties,
covenants and agreements shall survive the execution and delivery of this
Agreement and the Closing hereunder. Notwithstanding the foregoing, all
representations and warranties of the Company and Buyer respectively, contained
in this Agreement, on any Schedule or Exhibit hereto or in any instrument
delivered in connection with or pursuant to this Agreement shall terminate and
expire twelve (12) months after the date of Closing.

           (b) All representations and warranties of Buyer shall terminate and
expire twelve (12) months after the date of Closing; provided, however, that the
liability of Buyer shall not terminate as to any specific claim or claims of the
type referred to in Section 6.3 hereof, whether or not fixed as to Liability or
liquidated as to amount, with respect to which Buyer has been given specific
notice on or prior to the date on which such Liability would otherwise terminate
pursuant to the terms of this Section 6.1(b), or which arise or result from or
are related to a Claim for fraud.

     SECTION 6.2 Obligation of the Company to Indemnify. The Company, through
its shareholders, as provided in the Escrow Agreement, agrees to indemnify,
defend and hold harmless Buyer (and its respective directors, officers,
employees, Affiliates, successors and assigns) from and against all Claims,
losses, Liabilities, Regulatory Actions, damages, deficiencies, judgments,
settlements, costs of investigation or other expenses (including Taxes,
interest, penalties and reasonable attorneys' fees and fees of other experts and
disbursements and expenses incurred in enforcing this indemnification)
(collectively, the "Losses") suffered or incurred by Buyer, the Company, or any
of the foregoing persons arising out of any breach of the representations and
warranties of the Company contained in this Agreement, or of the covenants and
agreements of Company contained in this Agreement or in the Schedules, Exhibits
or any other Transaction Document.

     SECTION 6.3 Obligation of Buyer and Buyer Shareholder to Indemnify. Buyer
and the shareholder of Buyer set forth on Schedule 6.3 (the "Buyer Shareholder")
jointly and severally agree to indemnify, defend and hold harmless the Company

                                       23

<PAGE>

(and any heirs, successor or assignee thereof) from and against any Losses
suffered or incurred by the Company or any of the foregoing persons arising out
of any breach of the representations and warranties of Buyer, or of the
covenants and agreements of Buyer contained in this Agreement or in the
Schedules, Exhibits or any other Transaction Document.

     SECTION 6.4 Notice and Opportunity to Defend Third Party Claims. (a) Within
ten (10) days following receipt by any party hereto (the "Indemnitee") of notice
of any demand, claim, circumstance or Tax Audit which would or might give rise
to a claim, or the commencement (or threatened commencement) of any action,
proceeding or investigation that may result in a Loss (an "Asserted Liability"),
the Indemnitee shall give notice thereof (the "Claims Notice") to the party or
parties obligated to provide indemnification pursuant to Sections 6.2, or 6.3
(collectively, the "Indemnifying Party"). The Claims Notice shall describe the
Asserted Liability in reasonable detail and shall indicate the amount
(estimated, if necessary, and to the extent feasible) of the Loss that has been
or may be suffered by the Indemnitee.

           (b) The Indemnifying Party may elect to defend, at its own expense
and with its own counsel, any Asserted Liability unless: (i) the Asserted
Liability includes a Claim seeking an Order for injunction or other equitable or
declaratory relief against the Indemnitee, in which case the Indemnitee may at
its own cost and expense and at its option defend the portion of the Asserted
Liability seeking equitable or declaratory relief against the Indemnitee, or
(ii) the Indemnitee shall have reasonably, and in good faith, after consultation
with the Indemnifying Party, concluded that: (x) there is a conflict of interest
between the Indemnitee and the Indemnifying Party which could prevent or
negatively influence the Indemnifying Party from impartially or adequately
conducting such defense; or (y) the Indemnitee shall have one or more defenses
not available to the Indemnifying Party but only to the extent such defense
cannot legally be asserted by the Indemnifying Party on behalf of the
Indemnitee. If the Indemnifying Party elects to defend such Asserted Liability,
it shall within ten (10) days (or sooner, if the nature of the Asserted
Liability so requires) notify the Indemnitee of its intent to do so, and the
Indemnitee shall cooperate, at the expense of the Indemnifying Party, in the
defense of such Asserted Liability. If the Indemnifying Party elects not to
defend the Asserted Liability, is not permitted to defend the Asserted Liability
by reason of the first sentence of this Section 6.4(b), fails to notify the
Indemnitee of its election as herein provided or contests its obligation to
indemnify under this Agreement with respect to such Asserted Liability, the
Indemnitee may pay, compromise or defend such Asserted Liability at the sole
cost and expense of the Indemnifying Party. Notwithstanding the foregoing,
neither the Indemnifying Party nor the Indemnitee may settle or compromise any
claim over the reasonable written objection of the other, provided that the
Indemnitee may settle or compromise any claim as to which the Indemnifying Party
has failed to notify the Indemnitee of its election under this Section 6.4(b) or
as to which the Indemnifying Party is contesting its indemnification obligations
hereunder. If the Indemnifying Party desires to accept a reasonable, final and
complete settlement of an Asserted Liability so that such Indemnitee's Loss is
paid in full and the Indemnitee refuses to consent to such settlement, then the
Indemnifying Party's liability to the Indemnitee shall be limited to the amount
offered in the settlement. The Indemnifying Party will exercise good faith in
accepting any reasonable, final and complete settlement of an Asserted
Liability. In the event the Indemnifying Party elects to defend any Asserted

                                       24

<PAGE>

Liability, the Indemnitee may participate, at its own expense, in the defense of
such Asserted Liability. In the event the Indemnifying Party is not permitted by
the Indemnitee to defend the Asserted Liability, it may nevertheless participate
at its own expense in the defense of such Asserted Liability. If the
Indemnifying Party chooses to defend any Asserted Liability, the Indemnitee
shall make available to the Indemnifying Party any books, records or other
documents within its control that are necessary or appropriate for such defense.
Any Losses of any Indemnitee for which an Indemnifying Party is liable for
indemnification hereunder shall be paid upon written demand therefor.

     SECTION 6.5 Limits on Indemnification. (a) Notwithstanding the foregoing or
the limitations set forth in Section 6.5(b) below, in the event such Losses
arise out of any fraud related matter on the part of any Indemnifying Party,
then such Indemnifying Party shall be obligated to indemnify the Indemnitee in
respect of all such Losses. Buyer and the Company agree that the Buyer 's
obligation to indemnify under this Article VI shall not survive the Closing and
Buyer shall have no further liability to the Company after the Closing but that
such obligations to indemnify shall be the sole obligation of the Buyer
Shareholder.

           (b) The Company shall not be liable to indemnify Buyer pursuant to
Section 6.2 above and Buyer Shareholder shall not be liable to indemnify the
Company pursuant to Section 6.3 above: (i) unless a Claims Notice describing the
loss is delivered to the Indemnifying Party within 6 months after the Closing
(except for Losses arising out of an Indemnifying Party's fraud); and; (ii) with
respect to special, consequential or punitive damages; or (iii) in respect of
any individual Loss of less than $10,000. The Company's sole remedy for
indemnification from the Buyer Shareholder pursuant to Section 6.3 above shall
be cancellation or retirement of the Buyer Common Stock listed on Schedule 6.3;
provided, however, that for a period beginning on the six month anniversary of
the Closing Date and ending on the one year anniversary of the Closing Date,
only fifty percent (50%) of the Buyer Shareholder's Buyer Common Stock shall be
subject to cancellation or retirement.

     SECTION 6.6 Exclusive Remedy. The parties agree that the indemnification
provisions of this Article VI and the Escrow Agreement shall constitute the sole
or exclusive remedy of any party in seeking damages or other monetary relief
with respect to this Agreement and the Contemplated Transactions, provided that,
nothing herein shall be construed to limit the right of any party to seek: (i)
injunctive relief for a breach of this Agreement; (ii) legal or equitable relief
for a Claim for fraud; or (iii) indemnity under the bylaws of Buyer if they are
or have been a director or officer of Buyer.

                                  ARTICLE VII

                        SPECIFIC PERFORMANCE; TERMINATION

     SECTION 7.1 Specific Performance. The Company and Buyer acknowledges and
agrees that, if any of the Company or Buyer fails to proceed with the Closing in
any circumstance other than those described in clauses (a), (b), (c) or (d) of
Section 7.2 below, the others will not have adequate remedies at law with
respect to such breach. In such event, and in addition to each party's right to

                                       25

<PAGE>

terminate this Agreement, each party shall be entitled, without the necessity or
obligation of posting a bond or other security, to seek injunctive relief, by
commencing a suit in equity to obtain specific performance of the obligations
under this Agreement or to sue for damages, in each case, without first
terminating this Agreement. The Company or Buyer specifically affirms the
appropriateness of such injunctive, other equitable relief or damages in any
such action.

     SECTION 7.2 Termination. This Agreement may be terminated and the
Contemplated Transactions may be abandoned at any time prior to the Closing:

           (a) By mutual written consent of the Company and Buyer;

           (b) By the Company if: (i) there has been a misrepresentation or
breach of warranty on the part of Buyer in the representations and warranties
contained herein and such misrepresentation or breach of warranty, if curable,
is not cured within thirty days after written notice thereof from the Company;
(ii) Buyer has committed a breach of any covenant imposed upon it hereunder and
fails to cure such breach within thirty days after written notice thereof from
the Company; or (iii) any condition to the Company's obligations under Section
5.2 becomes incapable of fulfillment through no fault of the Company and is not
waived by the Company;

           (c) By Buyer, if: (i) there has been a misrepresentation or breach of
warranty on the part of the Company in the representations and warranties
contained herein and such misrepresentation or breach of warranty, if curable,
is not cured within thirty days after written notice thereof from Buyer; (ii)
the Company has committed a breach of any covenant imposed upon it hereunder and
fails to cure such breach within thirty days after written notice thereof from
Buyer; or (iii) any condition to Buyer's or Buyer's obligations under Section
5.3 becomes incapable of fulfillment through no fault of Buyer and is not waived
by Buyer; and

           (d) By the Company or by Buyer, if any condition under Section 5.1
becomes incapable of fulfillment through no fault of the party seeking
termination and is not waived by the party seeking termination.

     SECTION 7.3 Effect of Termination; Right to Proceed. Subject to the
provisions of Section 7.1 hereof, in the event that this Agreement shall be
terminated pursuant to Section 7.2, all further obligations of the parties under
this Agreement shall terminate without further liability of any party hereunder
except that: (i) the agreements contained in Section 4.2 and Section 4.3 shall
survive the termination hereof; and (ii) termination shall not preclude any
party from seeking relief against any other party for breach of Section 4.2 or
Section 4.3. In the event that a condition precedent to its obligation is not
met, nothing contained herein shall be deemed to require any party to terminate
this Agreement, rather than to waive such condition precedent and proceed with
the Contemplated Transactions.

                                       26

<PAGE>

     SECTION 7.4 Termination Fee. In the event the Closing does not occur due to
the failure of Company or its shareholders to perform and not due to a failure
of Buyer's performance or the obtaining of Buyer's shareholder approval for the
transaction, and Company's or its shareholders failure of performance is not
excused pursuant to the terms of this Agreement or waived by the Buyer, Company
shall make a one-time payment to Buyer within ten (10) days of receiving written
notice from Buyer of Buyer's demand, in the amount of $300,000 ("Company
Termination Fee"). In the event the Closing does not occur due to the failure of
Buyer to perform and not due to a failure of Buyer's shareholders to approve the
transactions described herein, Buyer shall make a one-time payment to Company
within ten (10) days of receiving written notice from Company of Company's
demand, in the amount of $50,000 plus all of Company's reasonable out-of-pocket
costs demonstrable to Buyer ("Buyer Termination Fee") .

                                  ARTICLE VIII

                                  MISCELLANEOUS

     SECTION 8.1 Notices. (a) Any notice or other communication required or
permitted hereunder shall be in writing and shall be delivered personally by
hand or by recognized overnight courier, or mailed (by registered or certified
mail, postage prepaid return receipt requested) as follows:

     If to Buyer, one copy to:

              BlueStar Health, Inc.
              19901 Southwest Freeway, Suite 205-206
              Sugar Land, TX  77479
              Attention:       Richard M. Greenwood
                               President and Chief Executive Officer

              With a copy to:

              Law Office of John D. Hannesson
              18661 Via Palatino
              Irvine, California 92603
              Attention:       John D. Hannesson, Esq.

     If to the Company, one copy to:

              Zeon Fuel, Inc.
              8822 Hazen Street
              Houston, TX  77036
              Attention:       Mr. Naved Jafry
                               Chairman

              With a copy to:

                                       27

<PAGE>

              Ronald M. Hall
              Attorney
              2830 Triway
              Houston, TX 770473

     Each such notice or other communication shall be effective when delivered
at the address specified in Section 8.1(a). Any party by notice given in
accordance with this Section 8.1 to the other parties may designate another
address or person for receipt of notices hereunder. Notices by a party may be
given by counsel to such party.

     SECTION 8.2 Entire Agreement. This Agreement (including the Schedules and
Exhibits hereto) and the collateral agreements executed in connection with the
consummation of the Contemplated Transactions contain the entire agreement among
the parties with respect to the subject matter hereof and related transactions
and supersede all prior agreements, written or oral, with respect thereto.

     SECTION 8.3 Waivers and Amendments; Non-Contractual Remedies; Preservation
of Remedies. This Agreement may be amended, superseded, cancelled, renewed or
extended only by a written instrument signed by the Company, Buyer. The
provisions hereof may be waived in writing by the Company Buyer, as the case may
be. Any such waiver shall be effective only to the extent specifically set forth
in such writing. No failure or delay on the part of any party in exercising any
right, power or privilege hereunder shall operate as a waiver thereof. Nor shall
any waiver on the part of any party of any such right, power or privilege, nor
any single or partial exercise of any such right, power or privilege, preclude
any other or further exercise thereof or the exercise of any other such right,
power or privilege. Except as otherwise provided herein, the rights and remedies
herein provided are cumulative and are not exclusive of any rights or remedies
that any party may otherwise have at law or in equity.

     SECTION 8.4 Governing Law. This Agreement shall be governed and construed
in accordance with the laws of the State of Texas applicable to agreements made
and to be performed entirely within such State without regard to the conflict of
laws rules thereof.

     SECTION 8.5 Consent to Jurisdiction. Each of the parties hereto irrevocably
and voluntarily submits to personal jurisdiction in the State of Texas and in
the Federal courts in such state in any action or proceeding arising out of or
relating to this Agreement and agrees that all claims in respect of such action
or proceeding may be heard and determined in any such court. If for any reason
the Federal courts in such state will not entertain such action or proceeding,
then the parties hereto irrevocably and voluntarily submit to personal
jurisdiction in the state courts located in the State of Texas in any action or
proceeding arising out of or relating to this Agreement and agree that all
claims in respect of any action or proceeding may be heard and determined in any
such court. Each of the parties further consents and agrees that such party may
be served with process in the same manner as a notice may be given under Section
8.1. The parties hereto agree that any action or proceeding instituted by any of
them against any other party with respect to this Agreement will be instituted
exclusively in the United States District Court for the District of Houston, or
alternatively, in the State courts located therein. The Company, and Buyer

                                       28

<PAGE>

irrevocably and unconditionally waive and agree not to plead, to the fullest
extent permitted by law, any objection that they may now or hereafter have to
the laying of venue or the convenience of the forum of any action or proceeding
with respect to this Agreement in any such courts.

     SECTION 8.6 Binding Effect; No Assignment. This Agreement and all of its
provisions, rights and obligations shall be binding upon and shall inure to the
benefit of the parties hereto and their respective successors, heirs and legal
representatives. This Agreement may not be assigned (including by operation of
Law) by any party hereto without the express written consent of Buyer (in the
case of assignment by the Company) or the Company (in the case of assignment by
Buyer) and any purported assignment, unless so consented to, shall be void and
without effect.

     SECTION 8.7 Exhibits. All Exhibits and Schedules attached hereto are hereby
incorporated by reference into, and made a part of, this Agreement.

     SECTION 8.8 Severability. If any provision of this Agreement for any reason
shall be held to be illegal, invalid or unenforceable, such illegality shall not
affect any other provision of this Agreement, this Agreement shall be amended so
as to enforce the illegal, invalid or unenforceable provision to the maximum
extent permitted by applicable law, and the parties shall cooperate in good
faith to further modify this Agreement so as to preserve to the maximum extent
possible the intended benefits to be received by the parties.

     SECTION 8.9 Counterparts. The Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original as against any
party whose signature appears thereon, and all of which shall together
constitute one and the same instrument. This Agreement shall become binding when
one or more counterparts hereof, individually or taken together, shall bear the
signatures of all of the parties reflected hereon as the signatories.

     SECTION 8.10 Third Parties. Except as specifically set forth or referred to
herein, nothing herein express or implied is intended or shall be construed to
confer upon or give to any person other than the parties hereto and their
permitted heirs, successors, assigns and legal representatives, any rights or
remedies under or by reason of this Agreement or the Contemplated Transactions.

                                   ARTICLE IX

                            POST CLOSING OBLIGATIONS

     SECTION 9.1 Capital Transactions. Buyer covenants to refrain from filing
any registration statement on Form S-8 with the SEC until after the first
anniversary of the Effective Time, and shall authorize no reverse stock split of
the common stock or any other series of outstanding security or take any other
actions dilutive of the common stock of Buyer, until after the first anniversary
of the Effective Time without the unanimous approval of the board of directors
of Buyer.

                                       29

<PAGE>

DEFINITIONS

     SECTION 9.2 Definitions. The following terms, as used herein, have the
following meanings:

     "Affiliate" of any person means any other person directly or indirectly
through one or more intermediary persons, controlling, controlled by or under
common control with such person.

     "Agreement" or "this Agreement" shall mean, and the words "herein",
"hereof" and "hereunder" and words of similar import shall refer to, this
agreement as it from time to time may be amended.

     "Assets" shall mean all cash, instruments, properties, rights, interests
and assets of every kind, real, personal or mixed, tangible and intangible, used
or usable in the Business.

     The term "audit" or "audited" when used in regard to financial statements
shall mean an examination of the financial statements by a firm of independent
certified public accountants in accordance with generally accepted auditing
standards for the purpose of expressing an opinion thereon.

     "Business" shall mean the ownership and operation of the business of the
Company.

     "Condition of the Business" shall mean the financial condition, prospects
or the results of operations of the Business, the Assets or the Company.

     "Contract" shall mean any contract, agreement, indenture, note, bond,
lease, conditional sale contract, mortgage, license, franchise, instrument,
commitment or other binding arrangement, whether written or oral.

     The term "control", with respect to any person, shall mean the power to
direct the management and policies of such person, directly or indirectly, by or
through stock ownership, agency or otherwise, or pursuant to or in connection
with an agreement, arrangement or understanding (written or oral) with one or
more other persons by or through stock ownership, agency or otherwise; and the
terms "controlling" and "controlled" shall have meanings correlative to the
foregoing.

     "GAAP" shall mean generally accepted accounting principles in effect on the
date hereof (or, in the case of any opinion rendered in connection with an
audit, as of the date of the opinion) as set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of
Certified Public Accountants and statements and pronouncements of the Financial

                                       30

<PAGE>

Accounting Standards Board or in such other statements by such other entity as
may be approved by a significant segment of the accounting profession of the
United States.

     "Governmental Bodies" shall mean any government, municipality or political
subdivision thereof, whether federal, state, local or foreign, or any
governmental or quasi-governmental agency, authority, board, bureau, commission,
department, instrumentality or public body, or any court, arbitrator,
administrative tribunal or public utility.

     "knowledge" with respect to: (a) any individual shall mean actual knowledge
of such individual; and (b) any corporation shall mean the actual knowledge of
the directors and executive officers of such corporation; and "knows" has a
correlative meaning. The terms "any Shareholder's knowledge," and "Shareholder's
knowledge," including any correlative meanings, shall mean the knowledge of any
Shareholder.

     "Laws" shall mean any law, statute, code, ordinance, rule, regulation or
other requirement of any Governmental Bodies.

     "Liability" shall mean any direct or indirect indebtedness, liability,
assessment, claim, loss, damage, deficiency, obligation or responsibility, fixed
or unfixed, choate or inchoate, liquidated or un-liquidated, secured or
unsecured, accrued, absolute, actual or potential, contingent or otherwise
(including any liability under any guaranties, letters of credit, performance
credits or with respect to insurance loss accruals).

     "Lien" shall mean any mortgage, lien (including mechanics, warehousemen,
laborers and landlords liens), claim, pledge, charge, security interest,
preemptive right, right of first refusal, option, judgment, title defect,
covenant, restriction, easement or encumbrance of any kind.

     "person" shall mean an individual, corporation, partnership, joint venture,
limited liability company, association, trust, unincorporated organization or
other entity, including a government or political subdivision or an agency or
instrumentality thereof.

     "Receivables" shall mean as of any date any trade accounts receivable,
notes receivable, sales representative advances and other miscellaneous
receivables of the Company.

     "SEC" means the United States Securities and Exchange Commission.

     "SEC Documents" means all forms, notices, reports, schedules, statements,
and other documents filed by Buyer with the SEC within the three years from the
Effective Time, whether or not constituting a "filed" document, and includes all
proxy statements, registration statements, amendments to registration
statements, periodic reports on Forms 10-KSB, 10-QSB, and 8-K, and annual and
quarterly reports to shareholders.

     "Tax" (including, with correlative meaning, the terms "Taxes" and
"Taxable") shall mean: (i)(A) any net income, gross income, gross receipts,
sales, use, ad valorem, transfer, transfer gains, franchise, profits, license,
withholding, payroll, employment, excise, severance, stamp, rent, recording,
occupation, premium, real or personal property, intangibles, environmental or
windfall profits tax, alternative or add-on minimum tax, customs duty or other

                                       31

<PAGE>

tax, fee, duty, levy, impost, assessment or charge of any kind whatsoever
(including but not limited to taxes assessed to real property and water and
sewer rents relating thereto), together with; (B) any interest and any penalty,
addition to tax or additional amount imposed by any Governmental Body (domestic
or foreign) (a "Tax Authority") responsible for the imposition of any such tax
and interest on such penalties, additions to tax, fines or additional amounts,
in each case, with respect to any party hereto, the Business or the Assets (or
the transfer thereof); (ii) any liability for the payment of any amount of the
type described in the immediately preceding clause (i) as a result of a party
hereto being a member of an affiliated or combined group with any other person
at any time on or prior to the date of Closing; and (iii) any liability of a
party hereto for the payment of any amounts of the type described in the
immediately preceding clause (i) as a result of a contractual obligation to
indemnify any other person.

     "Tax Return" shall mean any return or report (including elections,
declarations, disclosures, schedules, estimates and information returns)
required to be supplied to any Tax Authority.

     "Transaction Documents" shall mean, collectively, this Agreement, and each
of the other agreements and instruments to be executed and delivered by all or
some of the parties hereto in connection with the consummation of the
transactions contemplated hereby.

     SECTION 9.3 Interpretation. Unless the context otherwise requires, the
terms defined in this Agreement shall be applicable to both the singular and
plural forms of any of the terms defined herein. All accounting terms defined in
this Agreement, and those accounting terms used in this Agreement except as
otherwise expressly provided herein, shall have the meanings customarily given
thereto in accordance with GAAP as of the date of the item in question. When a
reference is made in this Agreement to Sections, such reference shall be to a
Section of this Agreement unless otherwise indicated. The headings contained in
this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement. The use of the neuter gender
herein shall be deemed to include the masculine and feminine genders wherever
necessary or appropriate, the use of the masculine gender shall be deemed to
include the neuter and feminine genders and the use of the feminine gender shall
be deemed to include the neuter and masculine genders wherever necessary or
appropriate. Whenever the words "include", "includes" or "including" are used in
this Agreement, they shall be deemed to be followed by the words "without
limitation."

            [THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

                                       32

<PAGE>

     IN WITNESS WHEREOF, the undersigned have executed this Stock Purchase and
Recapitalization Agreement as of the date set forth above.

                                            BUYER:
                                            BLUESTAR HEALTH, INC.

                                            By:  /s/  Richard M. Greenwood
                                               --------------------------------
                                                      Richard M. Greenwood
                                                      President and
                                                      Chief Executive Officer

                                            COMPANY:
                                            ZEON FUEL, INC.

                                            By:  /s/  Naved Jafry
                                               --------------------------------
                                                      Naved Jafry
                                                      Chairman

                                       33EXHIBIT 10.11

                              BLUESTAR HEALTH, INC.
                              ---------------------
                           CONVERTIBLE PROMISSORY NOTE
                           ---------------------------

$238,432.00                                                        March 1, 2007

FOR VALUE RECEIVED, Bluestar Health, Inc., a Colorado corporation, its assigns
and successors (the "Company"), hereby promises to pay to the order of Alfred
Oglesby, an individual, or his assigns (the "Holder"), in immediately available
funds, the total principal sum of Two Hundred Thirty Eight Thousand Four Hundred
Thirty Two Dollars ($238.432.00). The principal hereof plus the accrued interest
thereon ("Initial Interest Period") shall be due and payable in 20 equal
quarterly installments (collectively the "Repayment Period") of $16,441.83
commencing December 1, 2007 (the "Initial Payment Date") (unless such payment
date is accelerated as provided in Section 7 hereof). Payment of all amounts due
hereunder shall be made at the address of the Holder provided for in Section 8
hereof. Interest shall accrue during the Initial Interest Period and during the
Repayment Period at the rate of ten percent (10%) per annum on this Note from
the date hereof and shall continue to accrue until all unpaid principal and
interest is paid in full.

     1. HISTORY OF THE LOAN. This Note is being delivered to Holder as
consideration for amounts owed by the Company to the Holder for advances
previously made to the Company by the Holder. The Note replaces all other Notes
issued to the Holder previously issued to the Holder for advances made to the
Company except for the Note of even date representing previously earned but
unpaid compensation for services to the company (the "Compensation Note").

     2. PREPAYMENT. The Company may, at its option, at any time and from time to
time, prepay all or any part of the principal balance of this Note, without
penalty or premium, provided that concurrently with each such prepayment the
Company shall pay accrued interest on the principal, if any, so prepaid to the
date of such prepayment.

     3. SECURITY INTEREST. Holder will have a general security interest in all
company assets and contracts now and in the future until all principle and
interest under this Note are paid in full. The amount of security interest shall
be limited to the amount of principle and interest outstanding at the time such
time a Default exists as defined in Section 8 hereof. The Holder may call on his
right to the collateral provided by the Security Interest should the Default
remain past the time set aside to correct the Default in Section 8 hereof.
Principle and interest converted to shares of the Company's common stock as
provided in Section 4 hereof prior to such an event of Default will be excluded
from the calculation of amounts due at the time declares his rights to the
collateral on which the Holder has a Security Interest.

     4. CONVERSION. The Holder is entitled, at his option, at any time beginning
on the date hereof, and in whole or in part, to convert the outstanding
principal amount of this Note, or any portion of the principal amount hereof,
and any accrued interest, into shares of the common stock of the Company. Any
amounts Holder elects to convert will be converted into common stock at a
conversion price per share equal to Eighty percent (80%) of the average closing

                                  Page 1 of 5

<PAGE>

price of the Company's common stock over the most recent five (5) trading days
as quoted on a USA public exchange (the "Conversion Price"). Any conversion
shall be effectuated by giving a written notice ("Notice of Conversion") to the
Company on the date of conversion, stating therein the amount of principal and
accrued interest due to Holder under this Note being converted. If the Company
fails to deliver the shares of common stock due to Holder within seven (7) days
of receipt of a Notice of Conversion, Holder shall be entitled to receive a cash
payment equal to the difference between the fair market value of the shares of
common stock due to Holder on the date of delivery of the Notice of Conversion
and the total conversion price required to convert the shares of common stock
due to Holder (which amount shall be paid as liquidated damages and not as a
penalty).

     5. TRANSFERABILITY. This Note shall not be transferred, pledged,
hypothecated, or assigned by the Company without the express written consent of
the Holder. In the event any third party acquires a controlling interest in the
Company or acquires substantially all of the assets of the Company (a
"Reorganization Event"), this Note will survive and become an obligation of the
party that acquires such controlling interest or assets. In the event of a
Reorganization Event the Company agrees to make the party that acquires such
controlling interest or assets, aware of the terms of this Section and this
Note. This Note may be transferred, pledged, hypothecated, or assigned by the
Holder in his sole discretion.

     6. RESERVATION AND LISTING OF SECURITIES. The Company shall at all times
reserve and keep available out of its authorized shares of common stock, solely
for the purpose of issuance upon the conversion of this Note, such number of
shares of common stock as would be necessary to convert the entire amount due
and owing under the terms of this Note if Holder elected to convert said amount
under Section 3 hereof.

     7. DEFAULT. The occurrence of any one of the following events shall
constitute an Event of Default:

        (a) The non-payment, when due, of any principal or interest pursuant to
this Note;

        (b) The material breach of any representation or warranty in this Note.
In the event the Holder becomes aware of a breach of this Section 7(b), the
Holder shall notify the Company in writing of such breach and the Company shall
have five business days after notice to cure such breach;

        (c) The breach of any covenant or undertaking, not otherwise provided
for in this Section 7;

        (d) The commencement by the Company of any voluntary proceeding under
any bankruptcy, reorganization, arrangement, insolvency, readjustment of debt,
receivership, dissolution, or liquidation law or statute of any jurisdiction,
whether now or hereafter in effect; or the adjudication of the Company as
insolvent or bankrupt by a decree of a court of competent jurisdiction; or the
petition or application by the Company for, acquiescence in, or consent by the

                                  Page 2 of 5

<PAGE>

Company to, the appointment of any receiver or trustee for the Company or for
all or a substantial part of the property of the Company; or the assignment by
the Company for the benefit of creditors; or the written admission of the
Company of its inability to pay its debts as they mature; or

        (e) The commencement against the Company of any proceeding relating to
the Company under any bankruptcy, reorganization, arrangement, insolvency,
adjustment of debt, receivership, dissolution or liquidation law or statute of
any jurisdiction, whether now or hereafter in effect, provided, however, that
the commencement of such a proceeding shall not constitute an Event of Default
unless the Company consents to the same or admits in writing the material
allegations of same, or said proceeding shall remain undismissed for 20 days; or
the issuance of any order, judgment or decree for the appointment of a receiver
or trustee for the Company or for all or a substantial part of the property of
the Company, which order, judgment or decree remains undismissed for 20 days; or
a warrant of attachment, execution, or similar process shall be issued against
any substantial part of the property of the Company.

     Upon the occurrence of any Default or Event of Default, the Holder, may, by
written notice to the Company, declare all or any portion of the unpaid
principal amount due to Holder, together with all accrued interest thereon,
immediately due and payable, in which event it shall immediately be and become
due and payable, provided that upon the occurrence of an Event of Default as set
forth in paragraph (d) or paragraph (e) hereof, all or any portion of the unpaid
principal amount due to Holder, together with all accrued interest thereon,
shall immediately become due and payable without any such notice.

     8. NOTICES. Notices to be given hereunder shall be in writing and shall be
deemed to have been sufficiently given if delivered personally or sent by
overnight courier, or by facsimile transmission. Notice shall be deemed to have
been received on the date and time of personal or overnight delivery or
facsimile transmission, if received during normal business hours of the
recipient; if not, then on the next business day.

     Notices to the Company shall be sent to:    Bluestar Health, Inc.
                                                 19901 Southwest Freeway,
                                                 Suite 206
                                                 Sugar Land, TX 77479
                                                 Attn: President
                                                 Facsimile No.: (281) 207-5486

              with a copy to:                    John Hannesson, Esq.
                                                 18661 Via Palatino
                                                 Irvine, California  92612
                                                 Facsimile (949) 509-9867

     Notices to the Holder shall be sent to:     Alfred Oglesby
                                                 19901 Southwest Freeway,
                                                 Suite 205
                                                 Sugar Land, TX 77479
                                                 Facsimile No.:  (281) 207-5485

                                  Page 3 of 5

<PAGE>

     9. REPRESENTATIONS AND WARRANTIES. The Company hereby makes the following
representations and warranties to the Holder:

        (a) Organization, Good Standing and Power. The Company is a corporation
duly incorporated, validly existing and in good standing under the laws of the
State of Colorado and has the requisite corporate power to own, lease and
operate its properties and assets and to conduct its business as it is now being
conducted.

        (b) Authorization; Enforcement. The Company has the requisite corporate
power and authority to enter into and perform this Note and to issue and sell
this Note. The execution, delivery and performance of this Note by the Company,
and the consummation by it of the Transactions contemplated hereby, have been
duly and validly authorized by all necessary corporate action. This Note when
executed and delivered, will constitute a valid and binding obligation of the
Company enforceable against the Company in accordance with its terms, except as
such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation, conservatorship, receivership or
similar laws relating to, or affecting generally the enforcement of, creditor's
rights and remedies or by other equitable principles of general application.

        (c) Disclosure. Neither this Note nor any other document, certificate or
instrument furnished to the Holder by or on behalf of the Company in connection
with the transactions contemplated by this Note contains any untrue statement of
a material fact or omits to state a material fact necessary in order to make the
statements made herein or therein, in the light of the circumstances under which
they were made herein or therein, not misleading.

     10. PIGGYBACK REGISTRATION RIGHTS. If the Company at any time proposes to
conduct an offering of its securities so as to register any of its securities
under the Securities Act of 1933 (the "Act"), including under an S-1
Registration Statement or otherwise, it will at such time give written notice to
Holder, or its assigns, of its intention so to do. Upon the written request of
Holder, or assigns, given within 10 days after receipt of any such notice, the
Company will use its best efforts to cause the common stock underlying this note
to be registered under the Act (with the securities which the Company at the
time proposes to register).

     11. CONSENT TO JURISDICTION AND SERVICE OF PROCESS. The Company consents to
the jurisdiction of the courts of the State of Texas and of any state and
federal court located in the County of Harris, Texas.

     12. GOVERNING LAW. THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED AND
INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF TEXAS APPLICABLE TO
CONTRACTS MADE AND TO BE PERFORMED ENTIRELY THEREIN, WITHOUT GIVING EFFECT TO
THE RULES OR PRINCIPLES OF CONFLICTS OF LAW.

                                  Page 4 of 5

<PAGE>

     13. ATTORNEYS FEES. In the event the Holder hereof shall refer this Note to
an attorney to enforce the terms hereof, the Company agrees to pay all the costs
and expenses incurred in attempting or effecting the enforcement of the Holder's
rights, including reasonable attorney's fees, whether or not suit is instituted.

     14. CONFORMITY WITH LAW. It is the intention of the Company and of the
Holder to conform strictly to applicable usury and similar laws. Accordingly,
notwithstanding anything to the contrary in this Note, it is agreed that the
aggregate of all charges which constitute interest under applicable usury and
similar laws that are contracted for, chargeable or receivable under or in
respect of this Note, shall under no circumstances exceed the maximum amount of
interest permitted by such laws, and any excess, whether occasioned by
acceleration or maturity of this Note or otherwise, shall be canceled
automatically, and if theretofore paid, shall be either refunded to the Company
or credited on the principal amount of this Note.

     IN WITNESS WHEREOF, the Company has signed and sealed this Note and
delivered it as of March 1, 2007.

"Company"                                   "Holder"

Bluestar Health, Inc.,
a Colorado corporation

_________________________                   __________________________________
By:  Richard M. Greenwood                   By:  Alfred Oglesby, an individual
Its: President

                                  Page 5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]